#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13002	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2106	610.1	0	.	n	.	0	C451T	SNP	451	451	C	673	673	T	739	T,C	579,148	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13002	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2106	610.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1406	1406	C	704	C	688	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24320	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3612	668.9	0	.	n	.	0	T695C	SNP	695	695	T	1050	1050	C	746	C	736	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24320	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3612	668.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2326	2326	C	776	C,T	754,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24320	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3612	668.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2400	2400	A	789	A,G	768,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24320	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3612	668.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2952	2952	C	727	C,T,A	709,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24320	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3612	668.9	0	HET	.	.	.	A1638G	.	1638	1638	A	1993	1993	A	797	A,G	664,112	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24320	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3612	668.9	0	HET	.	.	.	C539T,A	.	539	539	C	894	894	C	802	C,T,A	652,119,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1630	folP	855	855	100.0	folP.l15.c4.ctg.1	1483	109.0	1	SNP	p	R229S	1	.	.	685	687	AGC	969	971	AGC	138;139;140	A;G;C	137;138;138	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4874	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3392	142.5	1	SNP	p	S91F	1	.	.	271	273	TTC	565	567	TTC	157;154;156	T;T;C	153;152;152	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4874	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3392	142.5	1	SNP	p	G95N	0	.	.	283	285	GGC	577	579	GGC	164;163;167	G;G;C	159;160;164	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4874	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3392	142.5	1	SNP	p	D95G	1	.	.	283	285	GGC	577	579	GGC	164;163;167	G;G;C	159;160;164	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1602	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1342	118.3	1	SNP	p	G45D	0	.	.	133	135	GGC	457	459	GGC	189;190;187	G;G,A;C	186;185,1;183	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	794	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	911	86.4	0	.	n	.	0	A197.	DEL	197	197	A	536	536	A	178	A	174	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4386	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2952	147.2	1	SNP	p	D86N	0	.	.	256	258	GAC	569	571	GAC	143;143;147	G;A,C;C	139;127,1;141	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4386	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2952	147.2	1	SNP	p	R87I	0	.	.	259	261	CGT	572	574	CGT	145;147;147	C;G;T	141;142;138	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4386	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2952	147.2	1	SNP	p	R87W	0	.	.	259	261	CGT	572	574	CGT	145;147;147	C;G;T	141;142;138	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4386	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2952	147.2	1	SNP	p	S87R	1	.	.	259	261	CGT	572	574	CGT	145;147;147	C;G;T	141;142;138	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4386	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2952	147.2	1	SNP	p	S88P	0	.	.	262	264	TCC	575	577	TCC	151;153;152	T,C;C,G;C	144,1;144,1;147	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3692	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2508	145.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1477	1479	GGC	182;177;178	G;G;C	178;173;170	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3282	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	137.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1270	1272	GCC	181;181;181	G,T;C;C	176,1;179;178	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3282	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	137.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1273	1275	ATG	181;182;179	A;T;G	178;180;175	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3282	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	137.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1285	1287	ACC	181;180;180	A;C,T;C	179;175,1;177	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3282	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	137.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1285	1287	ACC	181;180;180	A;C,T;C	179;175,1;177	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3282	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	137.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1786	1788	ACC	158;159;158	A;C;C	152;158;157	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3282	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	137.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1840	1842	GCG	171;169;169	G;C;G	166;164;164	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3282	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	137.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1840	1842	GCG	171;169;169	G;C;G	166;164;164	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3282	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	137.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1963	1965	GGT	122;121;121	G;G;T	121;117;117	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3282	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	137.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1972	1974	AGC	110;109;108	A;G;C	107;108;106	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3282	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	137.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1990	1992	CCG	92;92;91	C,G;C,G;G	85,1;84,1;69	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4928	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3207	152.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1589	1591	CCG	190;194;194	C;C;G	178;189;182	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2078	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1945	105.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	610	610	C	133	C,G	125,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2354	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1486	155.6	0	.	p	.	0	G210R	NONSYN	628	630	GGA	954	956	AGA	191;192;190	A;G;A	187;181;182	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2354	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1486	155.6	0	.	p	.	0	S217G	NONSYN	649	651	AGT	975	977	GGT	190;190;194	G;G;T	187;188;185	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2354	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1486	155.6	0	.	p	.	0	G252E	NONSYN	754	756	GGA	1080	1082	GAA	177;177;180	G;A,G;A	173;172,2;176	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2354	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1486	155.6	1	SNP	p	G120K	1	.	.	358	360	AAG	684	686	AAG	181;180;181	A;A;G,A	178;177;172,3	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2354	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1486	155.6	1	SNP	p	N121D	0	.	.	361	363	AAC	687	689	AAC	180;182;182	A;A;C	178;179;175	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2354	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1486	155.6	1	SNP	p	A121N	1	.	.	361	363	AAC	687	689	AAC	180;182;182	A;A;C	178;179;175	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8682	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4933	175.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1006	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1066	93.8	1	SNP	p	V57M	1	.	.	169	171	ATG	566	568	ATG	187;187;185	A;T;G	184;184;184	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
